This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abaci A., Saygi M., Yis U., Demir K., Dirik E., Bober E.: Metabolic alterations during valproic acid treatment: a prospective study. Pediatr. Neurol., 2009, 41: 435–439. doi: 10.1016/j.pediatrneurol.2009.06.00.AbaciA.SaygiM.YisU.DemirK.DirikE.BoberE.: Metabolic alterations during valproic acid treatment: a prospective study. Pediatr. Neurol., 2009, 41: 435–439. doi: 10.1016/j.pediatrneurol.2009.06.00.Open DOISearch in Google Scholar
Alphonse P.A.S., Ramprasath V., Jones P.J.H.: Effect of dietary cholesterol and plant sterol consumption on plasma lipid responsiveness and cholesterol trafficking in healthy individuals. British Journal of Nutrition, 2017, 117: 56–66. doi: 10.1017/S0007114516004530.AlphonseP.A.S.RamprasathV.JonesP.J.H.: Effect of dietary cholesterol and plant sterol consumption on plasma lipid responsiveness and cholesterol trafficking in healthy individuals. British Journal of Nutrition, 2017, 117: 56–66. doi: 10.1017/S0007114516004530.Open DOISearch in Google Scholar
Annegers J.F., Hauser W.A., Shirts S.B.: Heart disease mortality and morbidity in patients with epilepsy. Epilepsia, 1984, 25: 699–704.AnnegersJ.F.HauserW.A.ShirtsS.B.: Heart disease mortality and morbidity in patients with epilepsy. Epilepsia, 1984, 25: 699–704.10.1111/j.1528-1157.1984.tb03480.xSearch in Google Scholar
Antuna-Puentea B., Feve B., Fellahi S., Bastard J.P.: Adipokines: The missing link between insulin resistance and obesity. Diabetes & Metabolism, 2008, 34: 2–11. doi:10.1016/j.diabet.2007.09.004.Antuna-PuenteaB.FeveB.FellahiS.BastardJ.P.: Adipokines: The missing link between insulin resistance and obesity. Diabetes & Metabolism, 2008, 34: 2–11. doi:10.1016/j.diabet.2007.09.004.Open DOISearch in Google Scholar
Auley M.T.M., Mooney K.M.: Computationally Modelling Lipid Metabolism and Aging: A Mini-review. Computational and Structural Biotechnology Journal, 2015, 13, 38–46. doi: 10.1016/j.csbj.2014.11.006.AuleyM.T.M.MooneyK.M.: Computationally Modelling Lipid Metabolism and Aging: A Mini-review. Computational and Structural Biotechnology Journal, 2015, 13, 38–46. doi: 10.1016/j.csbj.2014.11.006.Open DOISearch in Google Scholar
Bacloer E., Kosari S., Stebbing M.J.: Resistin, an adipokine with non-generalized actions on sympathetic nerve activity. Frontier in Physiology, 2015, 6: 321. doi: 10.3389/fphys.2015.00321.BacloerE.KosariS.StebbingM.J.: Resistin, an adipokine with non-generalized actions on sympathetic nerve activity. Frontier in Physiology, 2015, 6: 321. doi: 10.3389/fphys.2015.00321.Open DOISearch in Google Scholar
Belcastro V., D’Egidio C., Striano P., Verrotti A.: Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Research, 2013, 107: 1–8. doi: 10.1016/j.eplepsyres.2013.08.016.BelcastroV.D’EgidioC.StrianoP.VerrottiA.: Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Research, 2013, 107: 1–8. doi: 10.1016/j.eplepsyres.2013.08.016.Open DOISearch in Google Scholar
Berenson G.S., Wattigney W.A., Tracy R.E., Newman W.P. 3rd, Srinivasan S.R., Webber L.S. et al.: Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am. J. Cardiol., 1992, 70: 851–858.BerensonG.S.WattigneyW.A.TracyR.E.NewmanW.P.3rdSrinivasanS.R.WebberL.S.: Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am. J. Cardiol., 1992, 70: 851–858.10.1016/0002-9149(92)90726-FSearch in Google Scholar
Chen S., Wu H., Klebe D., Hong Y., Zhang J.: Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries. Neurochem. Res., 2014, 39: 1621–1633. doi: 10.1007/s11064-014-1241-2.ChenS.WuH.KlebeD.HongY.ZhangJ.: Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries. Neurochem. Res., 2014, 39: 1621–1633. doi: 10.1007/s11064-014-1241-2.24482021Open DOISearch in Google Scholar
Egger J., Brett E.M.: Effects of sodium valproate in 100 children with special reference to weight. Br. Med. J., (Clin. Res. Ed.), 1981, 283: 577–581.EggerJ.BrettE.M.: Effects of sodium valproate in 100 children with special reference to weight. Br. Med. J., (Clin. Res. Ed.), 1981, 283: 577–581.10.1136/bmj.283.6291.57715069576790086Search in Google Scholar
Erdemir A., Cullu N., Yis U., Demircioglu F., Kir M., Cakmakci H. et al.: Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain & Development, 2009, 31: 713–716. doi: 10.1016/j.braindev.2008.11.001.ErdemirA.CulluN.YisU.DemirciogluF.KirM.CakmakciH.: Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid. Brain & Development, 2009, 31: 713–716. doi: 10.1016/j.braindev.2008.11.001.19064312Open DOISearch in Google Scholar
Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M.: Are oxidative stres-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes, 2003, 52: 1–8. doi: 10.2337/diabetes.52.1.1.EvansJ.L.GoldfineI.D.MadduxB.A.GrodskyG.M.: Are oxidative stres-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?Diabetes, 2003, 52: 1–8. doi: 10.2337/diabetes.52.1.1.12502486Open DOISearch in Google Scholar
Fan H.C., Lee H.S., Chang K.P., Lee Y.Y., Lai H.C., Hung P.L.: The impact of anti-epileptic drugs on growth and bone metabolism. Internat Journal of Molecular Sciences, 2016, 17: 1–22. doi:10.3390/ijms17081242FanH.C.LeeH.S.ChangK.P.LeeY.Y.LaiH.C.HungP.L.: The impact of anti-epileptic drugs on growth and bone metabolism. Internat Journal of Molecular Sciences, 2016, 17: 1–22. doi:10.3390/ijms1708124210.3390/ijms17081242500064027490534Search in Google Scholar
Ghodke-Puranik Y., Thorn C.F., Lamba J.K., Leeder J.S., Song W., Birnbaum A.K. et al.: Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics, 2013, 23: 236–241. doi: 10.1097/FPC.0b013e32835ea0b2.Ghodke-PuranikY.ThornC.F.LambaJ.K.LeederJ.S.SongW.BirnbaumA.K.: Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics, 2013, 23: 236–241. doi: 10.1097/FPC.0b013e32835ea0b2.369651523407051Open DOISearch in Google Scholar
Grootaert C., Van der Wiele T., Verstraete W., Bracke M., Vanhoecke B.: Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationship. Expert Review of Proteomics, 2012, 9: 181–199. doi:10.1586/epr.12.12.GrootaertC.Van der WieleT.VerstraeteW.BrackeM.VanhoeckeB.: Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationship. Expert Review of Proteomics, 2012, 9: 181–199. doi:10.1586/epr.12.12.22462789Open DOISearch in Google Scholar
Huang X., Yang Z.: Resistin’s, obesity, and insulin resistance: the continuing disconnect between rodents and humans. J. Endocrinol. Invest., 2016, 39: 607–615. doi: 10.1007/s40618-015-0408-2.HuangX.YangZ.: Resistin’s, obesity, and insulin resistance: the continuing disconnect between rodents and humans. J. Endocrinol. Invest., 2016, 39: 607–615. doi: 10.1007/s40618-015-0408-2.26662574Open DOISearch in Google Scholar
Klepper J., Voit T.: Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain – a review. Eur. J. Pediatr., 2002, 161: 295–304. doi: 10.1007/s00431-002-0939-3.KlepperJ.VoitT.: Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain – a review. Eur. J. Pediatr., 2002, 161: 295–304. doi: 10.1007/s00431-002-0939-3.12029447Open DOISearch in Google Scholar
Li Y., Ding L., Hassan W., Abdelkader D., Shang J.: Adipokines and hepatic insulin resistance. Journal of Diabetes Research, 2013, Article ID 170532. doi: 10.1155/2013/170532.LiY.DingL.HassanW.AbdelkaderD.ShangJ.: Adipokines and hepatic insulin resistance. Journal of Diabetes Research, 2013, Article ID 170532. doi: 10.1155/2013/170532.367057623762871Open DOISearch in Google Scholar
Li Y., Teng C.: Angiopoetin-like proteins 3, 4, and 8: regulating lipid metabolism and providing new hope for metabolic syndrome. Journal of Drug Targeting, 2014, 22: 679–687. doi: 10.3109/1061186X.2014.928715.LiY.TengC.: Angiopoetin-like proteins 3, 4, and 8: regulating lipid metabolism and providing new hope for metabolic syndrome. Journal of Drug Targeting, 2014, 22: 679–687. doi: 10.3109/1061186X.2014.928715.24960069Open DOISearch in Google Scholar
Luo X., Zhang M., Deng L., Zhao J.: Effects of valproate on the carotid artery intima-media thickness in epileptics. Indian Journal of Pharmacology, 2015, 47: 45–48. doi: 10.4103/0253-7613.150328.LuoX.ZhangM.DengL.ZhaoJ.: Effects of valproate on the carotid artery intima-media thickness in epileptics. Indian Journal of Pharmacology, 2015, 47: 45–48. doi: 10.4103/0253-7613.150328.437581825821310Open DOISearch in Google Scholar
Nagasawa S.Y., Okamura T., Iso H., Tamakoshi A., Yamada M., Watanabe M. et al.: Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan. J. Am. Heart Assoc., 2012, 1: e001974. doi: 10.1161/JAHA.112.001974.NagasawaS.Y.OkamuraT.IsoH.TamakoshiA.YamadaM.WatanabeM.: Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan. J. Am. Heart Assoc., 2012, 1: e001974. doi: 10.1161/JAHA.112.001974.Open DOISearch in Google Scholar
Park H.K., Kwak M.K., Kim H.J., Ahima R.S.: Linking resistin, inflammation and cardiometabolic diseases. Korean J. Intern. Med., 2017, 32: 239–247. doi: 10.3904/kjim.2016.229.ParkH.K.KwakM.K.KimH.J.AhimaR.S.: Linking resistin, inflammation and cardiometabolic diseases. Korean J. Intern. Med., 2017, 32: 239–247. doi: 10.3904/kjim.2016.229.Open DOISearch in Google Scholar
Płonka-Półtorak E., Zagrodzki P., Kryczyk-Kozioł J., Westermarck T., Kaipainen P., Kaski M., Atroshi F.: Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids. Pharmacological Reports, 2016, 68: 1339–1344. doi: 10.1016/j.pharep.2016.09.001.Płonka-PółtorakE.ZagrodzkiP.Kryczyk-KoziołJ.WestermarckT.KaipainenP.KaskiM.AtroshiF.: Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids. Pharmacological Reports, 2016, 68: 1339–1344. doi: 10.1016/j.pharep.2016.09.001.Open DOISearch in Google Scholar
Sakakura K., Nakano M., Otsuka F., Ladich E., Kolodgie F.D., Virmani R.: Pathophysiology of atherosclerosis plaque progression. Heart, Lung, and Circulation, 2013, 22: 399–411. doi: 10.1016/j.hlc.2013.03.001.SakakuraK.NakanoM.OtsukaF.LadichE.KolodgieF.D.VirmaniR.: Pathophysiology of atherosclerosis plaque progression. Heart, Lung, and Circulation, 2013, 22: 399–411. doi: 10.1016/j.hlc.2013.03.001.Open DOISearch in Google Scholar
Silva M.F., Aires C.C., Luis P.B., Ruiter J.P., Jist L.I., Duran M. et al.: Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J. Inherit. Metab. Dis., 2008, 31: 205–216. doi: 10.1007/s10545-008-0841-x.SilvaM.F.AiresC.C.LuisP.B.RuiterJ.P.JistL.I.DuranM.: Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J. Inherit. Metab. Dis., 2008, 31: 205–216. doi: 10.1007/s10545-008-0841-x.Open DOISearch in Google Scholar
Sozio M.S., Liangpunsakul S., Crabb D.: The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Seminars in Liver Disease, 2010, 30: 378–390. doi: 10.1055/s-0030-1267538.SozioM.S.LiangpunsakulS.CrabbD.: The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Seminars in Liver Disease, 2010, 30: 378–390. doi: 10.1055/s-0030-1267538.Open DOISearch in Google Scholar
Terbach N., Williams R.S.: Structure-function studies for the panacea, valproic acid. Biochemical Society Transaction, 2009, 37: 1126–1132. doi: 10.1042/BST0371126.TerbachN.WilliamsR.S.: Structure-function studies for the panacea, valproic acid. Biochemical Society Transaction, 2009, 37: 1126–1132. doi: 10.1042/BST0371126.Open DOISearch in Google Scholar
Titchenell P.M., Lazar M.A., Birnbaum M.J.: Unraveling the regulation of hepatic metabolism by insulin. Trends in Endocrinology & Metabolism, 2017, 28: 497–505. doi: 10.1016/j.tem.2017.03.003.TitchenellP.M.LazarM.A.BirnbaumM.J.: Unraveling the regulation of hepatic metabolism by insulin. Trends in Endocrinology & Metabolism, 2017, 28: 497–505. doi: 10.1016/j.tem.2017.03.003.Open DOISearch in Google Scholar
Tomson T., Battino D., Perucca E.: Valproic acid after five decades of use in epilepsy: time to reconsider the indications of time-honoured drug. Lancet Neurol., 2016, 15: 210–218. doi: 10.1016/S1474-4422(15)00314-2.TomsonT.BattinoD.PeruccaE.: Valproic acid after five decades of use in epilepsy: time to reconsider the indications of time-honoured drug. Lancet Neurol., 2016, 15: 210–218. doi: 10.1016/S1474-4422(15)00314-2.Open DOISearch in Google Scholar
Verrotti A., Torre R.L., Trotta D., Mohn A., Chiarelli F.: Valproate-induced insulin resistance and obesity in children. Horm. Res., 2009, 71: 125–131.VerrottiA.TorreR.L.TrottaD.MohnA.ChiarelliF.: Valproate-induced insulin resistance and obesity in children. Horm. Res., 2009, 71: 125–131.10.1159/00019786819188736Search in Google Scholar
Wahyuni K.D., Was’an M.: Korelasi antara Durasi Terapi Obat Antiepilepsi Generasi Pertama dengan Kadar Profil Lipid pada Penyandang Epilepsi Idiopatik. Postgraduate Thesis, Universitas Gajah Mada, 2013, Yogyakarta Indonesia.WahyuniK.D., Was’anM.: Korelasi antara Durasi Terapi Obat Antiepilepsi Generasi Pertama dengan Kadar Profil Lipid pada Penyandang Epilepsi Idiopatik. Postgraduate Thesis, Universitas Gajah Mada, 2013, Yogyakarta Indonesia.Search in Google Scholar
Wang Y., Ma X.L., Lau W.B.: Cardiovascular adiponectin resistance: the critical role of adiponectin receptor modification. Trends in Endocrinology & Metabolism, 2017, 28: 519–530. doi: 10.1016/j.tem.2017.03.004.WangY.MaX.L.LauW.B.: Cardiovascular adiponectin resistance: the critical role of adiponectin receptor modification. Trends in Endocrinology & Metabolism, 2017, 28: 519–530. doi: 10.1016/j.tem.2017.03.004.639199528473178Open DOISearch in Google Scholar
